Case File
efta-01775143DOJ Data Set 10OtherEFTA01775143
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01775143
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Barrett, Paul S ile>
Sent:
Wednesday, September 21, 2011 7:52 PM
To:
Jeffrey Epstein
Subject:
Update
Hi=Jeffrey
<= class=MsoNormal>We are still doing some more credit work before we close the=55MM Harrah's note.
&nbs=;
Since the end of August the account is d=wn around $2.7MM (was flat at the end of Aug).This translates into -
$6=2E98MM for 2010 and +$4.25MM YTD for 2011.
This has been due to =changes since End of August):
&n=sp;
SGD down 5% ($500K)<=p>
INR down 5%($500K
-
&nb=p; We switched both of these forwar=s into options so we have limited downside from here on out
CADJPY down 150K [We are long the 83.25 CAD Call a=d Short the 76.00 Put with a knock in at 71; spot at 76.50; knoc=
in 7% away)
Oil call down 140K<=o:p>
Corn down 600K
ING Pfds down 200K
MS =ote knocked in down 140K
Telefonica n=te down 300K [Stock is trading below 2009 lows; only 35% of their revenue =omes from Spain; would
HOLD]
&nb=p;
I would like to reduce further downside=2E
EFTA_R1_00088942
EFTA01775143
I think the cheapest protection out there remains buying CDS on=Asia. For example Indonesia CDS costs 220bps. It got as
wide as 1200bp= in 2008. It feels like Asian credit spreads remain one of the few thing= that have not moved and could
provide some cheaper tail risk if things de=eriorate further.
Financial Pfds remain our largest notional expo=ure (around $20MM). I think we should reduce some exposure here.
Would=involve selling some of IPM, Barclays and Citigroup. BAC and WFC was dow=graded today and would also trim
those positions.
<= class=MsoNormal>
Do you have time=to discuss?
<=p>
Paul
Paul Barrett, CFA
Man=ging Director
Global Investment Oppor=unities Group
JPMorgan Private Bank
, New York, =Y 10019
(W)
(F)
This email is confidential and subj=ct to important disclaimers and conditions including on offers for the pur=hase or sale
of securities, accuracy and completeness of information, viru=es, confidentiality, legal privilege, and legal entity
disclaimers, availa=le at http://www.jpmorgan.com/pages/disclosures/email.
2
EFTA_R1_00088943
EFTA01775144
Technical Artifacts (1)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
URL
http://www.jpmorgan.com/pages/disclosures/emailRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.